To determine the combined effect of enzalutamide treatment and ABCC5 depletion on inhibition of tumor proliferation and promotion of apoptosis, immunofluorescence staining for Ki67 and cleaved caspase 3 was performed on xenograft tumor slices (Fig. 4F). The gene discussed is ABCC5; the disease is neoplasm.